Literature DB >> 22976585

Clinical outcomes of xeno-free allogeneic cultivated limbal epithelial transplantation for bilateral limbal stem cell deficiency.

Sayan Basu1, Mark M Fernandez, Sujata Das, Subhash Gaddipati, Geeta K Vemuganti, Virender S Sangwan.   

Abstract

PURPOSE: To report the clinical outcomes of allogeneic cell-based therapy for bilateral corneal blindness due to limbal stem cell deficiency (LSCD).
METHODS: This retrospective study included 28 eyes of 21 patients, at least 8 years of age, with bilateral and total LSCD, treated between 2001 and 2010. A limbal biopsy was obtained from the eye of an adult living related donor. The limbal epithelial cells were cultivated in the laboratory using a xeno-free explant culture technique and transplanted onto the recipient eye after 10-14 days. All transplant recipients received topical and systemic immunosuppressants.
RESULTS: At a mean follow-up of 4.8 ± 2.8 years, 20 (71.4%) eyes maintained a completely epithelised, avascular and stable corneal surface, and among them 13 (46.4%) eyes subsequently underwent a penetrating keratoplasty (PK). The Kaplan-Meier survival rate of the PK allograft was 76.9 ± 11.7% at 1 year with a median survival of 3.3 years. Visual acuity improved to 20/60 or better in 19 (67.8%) eyes. No donor or recipient eyes developed serious ocular complications.
CONCLUSIONS: Allogeneic cultivated limbal epithelial transplantation, followed by PK when needed, can successfully restore the ocular surface and improve vision in patients with corneal blindness due to bilateral LSCD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22976585     DOI: 10.1136/bjophthalmol-2012-301869

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  29 in total

1.  Successful acute and late management of a chemical burn with primary implantation of Boston type 1 keratoprosthesis.

Authors:  Abhishek Ranjan; Sirisha Senthil; Virender Sangwan
Journal:  BMJ Case Rep       Date:  2015-08-26

Review 2.  Stem Cells in the Cornea.

Authors:  Andrew J Hertsenberg; James L Funderburgh
Journal:  Prog Mol Biol Transl Sci       Date:  2015-05-27       Impact factor: 3.622

Review 3.  Outcomes of Limbal Stem Cell Transplant: A Meta-analysis.

Authors:  Qihua Le; Tulika Chauhan; Madeline Yung; Chi-Hong Tseng; Sophie X Deng
Journal:  JAMA Ophthalmol       Date:  2020-06-01       Impact factor: 7.389

4.  Optimal isolation and xeno-free culture conditions for limbal stem cell function.

Authors:  Kalliopi Stasi; DaVida Goings; Jiayan Huang; Lindsay Herman; Filipa Pinto; Russell C Addis; Dahlia Klein; Giacomina Massaro-Giordano; John D Gearhart
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-01-20       Impact factor: 4.799

Review 5.  An update on chemical eye burns.

Authors:  Mukhtar Bizrah; Ammar Yusuf; Sajjad Ahmad
Journal:  Eye (Lond)       Date:  2019-05-13       Impact factor: 3.775

6.  Presence of native limbal stromal cells increases the expansion efficiency of limbal stem/progenitor cells in culture.

Authors:  Sheyla González; Sophie X Deng
Journal:  Exp Eye Res       Date:  2013-09-07       Impact factor: 3.467

Review 7.  Concise review: the coming of age of stem cell treatment for corneal surface damage.

Authors:  Charanya Ramachandran; Sayan Basu; Virender S Sangwan; Dorairajan Balasubramanian
Journal:  Stem Cells Transl Med       Date:  2014-09-09       Impact factor: 6.940

Review 8.  Contact Lens-induced Limbal Stem Cell Deficiency.

Authors:  Jennifer Rossen; Alec Amram; Behrad Milani; Dongwook Park; Jennifer Harthan; Charlotte Joslin; Timothy McMahon; Ali Djalilian
Journal:  Ocul Surf       Date:  2016-07-30       Impact factor: 5.033

Review 9.  The application of human amniotic membrane in the surgical management of limbal stem cell deficiency.

Authors:  Qihua Le; Sophie X Deng
Journal:  Ocul Surf       Date:  2019-01-08       Impact factor: 5.033

10.  Existence of Normal Limbal Epithelium in Eyes With Clinical Signs of Total Limbal Stem Cell Deficiency.

Authors:  Eric Chan; Qihua Le; Andres Codriansky; Jiaxu Hong; Jianjian Xu; Sophie X Deng
Journal:  Cornea       Date:  2016-11       Impact factor: 2.651

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.